VHCP Management II as of Sept. 30, 2018
Portfolio Holdings for VHCP Management II
VHCP Management II holds 21 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Endocyte | 20.0 | $75M | 4.2M | 17.76 | |
| Biohaven Pharmaceutical Holding | 14.2 | $53M | 1.4M | 37.55 | |
| Obseva Sa | 10.8 | $41M | 2.3M | 18.03 | |
| Ascendis Pharma A S (ASND) | 9.5 | $36M | 504k | 70.86 | |
| Tricida | 7.8 | $29M | 963k | 30.55 | |
| BioCryst Pharmaceuticals (BCRX) | 6.6 | $25M | 3.2M | 7.63 | |
| Zogenix | 4.8 | $18M | 362k | 49.60 | |
| Kalvista Pharmaceuticals (KALV) | 4.5 | $17M | 759k | 22.11 | |
| Kiniksa Pharmaceuticals (KNSA) | 4.3 | $16M | 639k | 25.50 | |
| Dbv Technologies S A (DBVT) | 3.8 | $14M | 463k | 30.41 | |
| Ra Pharmaceuticals | 2.6 | $9.9M | 545k | 18.09 | |
| Argenx Se (ARGX) | 2.5 | $9.2M | 122k | 75.55 | |
| Momenta Pharmaceuticals | 1.9 | $6.9M | 263k | 26.30 | |
| Spero Therapeutics (SPRO) | 1.3 | $5.0M | 474k | 10.51 | |
| Constellation Pharmceticls I | 1.3 | $4.9M | 727k | 6.73 | |
| Kadmon Hldgs | 1.3 | $4.7M | 1.4M | 3.34 | |
| Bellerophon Therapeutics | 1.2 | $4.5M | 4.1M | 1.08 | |
| Marinus Pharmaceuticals | 1.1 | $4.0M | 397k | 10.00 | |
| Gemphire Therapeutics | 0.3 | $1.1M | 514k | 2.06 | |
| Apellis Pharmaceuticals (APLS) | 0.1 | $528k | 30k | 17.77 | |
| Chemocentryx | 0.1 | $292k | 23k | 12.66 |
